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There have been many attempts to isolate infectious agents from patients with multiple scle-
rosis (MS), and many viruses have been incriminated at one time or another over the past few
decades. However, in every case further research has disproved the original claim. Thus, we
cautiously report on the isolation of four antigenically related agents from the cerebrospinal
fluid (CSF) of three patients with MS and one patient with amyotrophic lateral sclerosis. The
patients yielding the isolates from their CSF possessed neutralizing antibodies to the virus in
their blood, in contrast to several other virus-free patients with chronic central nervous system
(CNS) diseases studied at the same time. The virus could not be isolated from 27 patients who
were not suffering from chronic disease of the CNS. The agent has not yet been adequately
characterized, but it deserves further attention because it seems to be a hitherto unknown virus,
difficult to isolate and difficult to work with in the laboratory. Its isolation from the four pa-
tients mentioned above (and subsequently in several other MS patients) warrants further in-
vestigation of its potential role in MS and other progressive diseases of the CNS.
Multiple sclerosis (MS), a progressive disease of the white matter of the central
nervous system (CNS), is characterized by ataxia, spasticity, visual impairment, and
sensory changes. The disease is the result of a loss of myelin, producing a lesion or
plaque which grows by extending its boundary. Small lesions may also merge into
confluent plaques. The myelin-producing cells, the oligodendrocytes, are lost from
the center of the plaque and astrocytes proliferate at the periphery. MS is an inflam-
matory disease with lymphocytes, plasma cells, and macrophages present within the
lesions.
MS occurs in genetically predisposed persons who appear to have an abnormal
immunoregulatory activity. Over 250,000 patients are affected in the United States.
The prevalence in the northern temperate regions (northern Europe, Canada, north-
ern United States) is higher than in the lower latitudes (southern United States, Med-
iterranean area): about 100 compared to about 30 per 100,000. It is much less com-
mon in the Japanese and Chinese, although in the Orient there is more optic neuritis
and spinal cord involvement and the overall disease may be more malignant.
The current status of knowledge has been well summarized by Waksman [1]: MS
may be an autoimmune disease involving some antigen ofmyelin or of the oligoden-
droglia cell which makes myelin; alternatively, MS may be caused by either an
unknown virus (perhaps a slow virus) or a familiar virus like measles, or indeed the
disease may represent an abnormal response to any of several common viruses. The
autoimmune theory is supported by an animal model, experimental autoallergic
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encephalomyelitis. Viral infections initiating an autoimmune process in genetically
predisposed hosts would reconcile the two hypotheses.
A viral etiology is supported by the epidemiology of MS. Its onset is usually be-
tween the ages of 15 and 50, but chiefly in young adults, with females outnumbering
males. The frequency of the disease in those migrating between areas of high and
low prevalence is age-dependent. Those who migrate after the age of 15 develop MS
with the same frequency as those in the area they come from, whereas those who
migrate in childhood develop MS with the frequency of those in the region they
migrate to.
Patients usually live for 30 years or more after the onset of illness. Although most
remain ambulatory for the first 15 years or so, the quality oftheir lives suffers from
the crippling neurologic defects. Many attempts have been made to isolate an agent
from MS patients, but the isolations have been sporadic and could not be confirmed
in further studies. Some of the reported isolations seem to have been pick-ups from
the laboratory or from the inoculated animals.
A number of animal disease models have been recognized or developed which
have similarities with MS. As shown in Table 1, they include viral infections alone or
combined with immunologic defects. Waksman [1] summarizes these observations:
"Theiler's virus induces an MS-like state only in SJL mice. It is thought therefore
that this disease may be due to an autoimmune process, triggered by the viral infec-
tion in a genetically defective host. On the other hand, mutants of the JHM virus
give a chronic demyelinative disease by infecting oligodendroglia to the exclusion of
other cells. Experimental autoallergic encephalomyelitis (EAE) has been investi-
gated for just a halfcentury. Yet it is only in the last decade that a chronic, relapsing
EAE closely resembling MS has been studied in any detail. Since this disease is readily
produced in SJL mice and not in other mice strains, there is again an implication
that defective immune regulation permits development of a chronic, relapsing auto-
immune state. In other animal species, this relationship is less clearcut." Thus, the
animal model studies support the idea that MS may be the result of a chronic viral
infection with a genetically determined abnormality of immune regulation.
Serological studies show that MS patients have higher antibody titers against
measles virus than do controls and a higher frequency of antibody in the cerebro-
spinal fluid (CSF) [2]. However, antibodies are high not only against measles virus
but also against a number of other viruses, including herpes, vaccinia, varicella-
TABLE 1
Animal Models for Multiple Sclerosis
Immunologic disease
Acute EAE* Many species
Chronic, relapsing EAE Monkey, guinea pig, rat, mouse
Virus disease
Canine distemper virus Dog, mouse
Murine (hepatitis) coronavirus Mouse
Murine poliovirus (Theiler's virus) SJL mouse
Visna virus Sheep
Combined
EAE + measles Hamster
EAE + subacute sclerosing
panencephalitis measles Ferret
*EAE (experimental autoallergic encephalomyelitis) is the result of immunizing animals with myelin or
myelin antigens.
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zoster, influenza, mumps, and rubella. Thesignificance ofthese high antibodylevels
is unknown, but they probably result from the deranged immunologic response. In
his review, Norrby [2] writes that the high levels may hinge upon "a nonspecific im-
mune activation of immune-competent cells that were once conditioned to produce
antibodies. This possibility is supported by the observation that the oligoclonal IgG
represents antibodies against several different viruses and presumably other anti-
gens. It is known from studies on the occurrence of oligoclonal IgG in sera of pa-
tients with different diseases that 'non-specific' activation of immunoglobulin pro-
duction may occur both as a result oflymphoproliferative disorders and also secon-
dary to neoplastic disorders of cell types not known to produce immunoglobulins,
diseases of suspected autoimmune origin (e.g., chronic active hepatitis), chronic in-
fections, parasitic diseases, and liver cirrhosis."
To search for the presence oflatent viruses that are in anoninfectious state, radio-
active probes can now be used. With this technique, the measles virus genome has
been detected in the brain tissue of four of ten patients who died of MS [3], and
DNA sequences ofherpes simplex virus have been found in braintissue, but in tissue
from normals as well as from MS patients [4].
Our approach has been to look once again for infectious virus based on observa-
tions originally made in Japan on patients suffering from aprogressive CNS disease.
Ten years ago [5] a virus was isolated in Japan from the CSF of patients suffering
from subacute myelo-optico-neuropathy (SMON), a finding which other investiga-
tors disputed [6]. Because so much difficulty was reported in working with the
original isolate, we set out to determine if we could establish conditions for obtain-
ing reproducible titrations ofthe virus and for conducting neutralization tests. Once
this objective was met, we attempted the isolation of virus from 12 consecutively
taken samples of CSF of Houstonian patients with chronic CNS disease. Four iso-
lates were made-three from patients with MS and one from a patient with amyo-
trophic lateral sclerosis (ALS)-and none from 27 CSF specimens from "control"
patients.
Human diploid fibroblasts, strain MRC5, were used as recommended by
Nishimura [7]. For our most consistent results, cells were used between the thirtieth
and fortieth passage. Cells in the earlier passages grew very well, but the virus-
induced changes were not as readily seen as in the older cells. Beyond the fortieth
passage, growth was slow and sparse.
A great deal of time was spent during the past three years [8] systematically in-
vestigating the optimal conditions for titration of the virus and for carrying out
neutralization tests. For a period of several months our work was disrupted and
could only be put back on track when we improved the quality of our water. For
detection of virus, a cell monolayer was used in the shape of an elongated triangle,
which formed when tube cultures were prepared in a stationary, slightly inclined
position. After virus inoculation, the cultures were rolled and thecytopathic changes
were examined primarily at the boundarybetween the cell monolayer and theculture
fluid. When virus was present, the cells lost their parallel orientation and criss-
crossed with each other. Some cells retracted and clear spaces appeared on the glass
surface. Some cells swelled and granules appeared within them. Crucial to the inter-
pretation of the results of each test was the requirement (a) that each test which was
set up by one worker be read independently by two or three persons, (b) that the
result of a coded titration be the same as that of an open titration, and (c) that
uninoculated cell controls be recorded as normal (see Figs. I and 2).
Neutralization tests were set up by mixing 0.5 ml of virus suspension containing
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i][ W :t FIG. 1. Uninfected human diploid
.. .. ...... fibroblasts.
100 TCDso per 0.1 ml with 0.5 ml of the serum diluted 1:25 or greater. The mixtures
were incubated for 1 hour at 37°C and then randomly coded; 0.2 ml of each coded
sample was inoculated in each of three cultures. The cultures were rolled at 37°C
and examined on day 5. Then, without knowledge ofthe results ofthis reading, they
were examined again on day 6. Virus titrations were included in each test to assure
the infectivity of the agent. At the end of the test, the results of the virus titration
and the virus-serum mixtures were decoded.
Specimens from 12 patients with persistent CNS disease were obtained in the
order in which they were hospitalized, during the first fortnight of March 1979. The
CSF was tested for virus by inoculation of 0.1 ml of 1:10 dilution into each of four
cultures. Four specimens were positive and repeat tests on the frozen spinal fluid
were also positive. Passages were made and the virus used in the neutralization test
as passages 3 and 4, when the virus isolates titered from 1050° to 106-5 per ml. The pa-
tients were all adults; their diagnoses and the results of virus isolations are given in
Table 2.
In addition to the spinal fluids of the above patients, ten specimens taken from
children and 17 from adults whose spinal taps were taken for diagnostic purposes
unrelated to chronic CNS illness were tested. All 27 were negative.
Table 3 lists the results of the coded neutralization tests in which sera from the 12
FIG 2. Infected cultures on the 6th
day after addition of virus.
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TABLE 2
Results of Virus Isolations from Patients with Chronic Degenerative CNS Disease
Duration of Virus
Patient Age Sex Clinical diagnosis disease isolation
1 67 M ALS I year +
2 23 F Seizures 2 months -
3 32 F Muscle weakness 3 years -
4 34 F Muscle atrophy 11 years -
5 25 M Peripheral neuropathy 13 years -
6 45 F MS 2 years +
7 42 F Probable MS 2 years
8 35 F Muscle weakness 5 years
9 25 F Possible MS 2 months +
10 50 F Cerebellar degeneration 8 years
11 21 F MS I year
12 31 F MS 13 years +
chronically ill patients were tested against the four isolates. Neutralizing antibodies
were detected in the four patients who yielded virus. Each of the four patients
neutralized his own virus plus the other three viruses, except for patient number 12,
who failed to neutralize isolate number 6. Serum of the other patients who failed to
yield virus almost completely failed to neutralize the isolated viruses.
The viruses isolated in Houston are antigenically related to SMON virus isolated
in Japan [8]. However, the viruses do not seem to be identical since the neutralizing
serum endpoints of antisera prepared in rabbits varied with the different isolates.
At least ten viruses have been suggested by earlier investigators to be the cause of
MS, but subsequent investigation has disproved the original claim [1,91. Thus, it is
with considerable caution that we present our results and emphasize the need for ex-
tensive further work before a claim can be made that the viruses isolated were
causally related to either MS or ALS.
For detection ofthe virus, we found that human diploid cultures after the thirtieth
passage responded better than the more vigorously growing cells of early passages.
The virus produced mild changes in the cells, changes easily overlooked or
sometimes confused with changes seen in aging cultures. It is for this reason we in-
sisted that all inoculations be coded and that the readings of the test cultures be
made under code by at least two investigators.
It is noteworthy that the presence of virus in the CSF was associated with serum
neutralizing antibody in the same patient. Antibody was detected in only three of 32
tests conducted with the sera ofthe eight patients who failed to yield virus. The link-
ing ofvirus in the CSF with serum antibody is similar to the situation in rubella arth-
TABLE 3
Neutralization Tests
Results of antibody tests
against virus isolates
No. Isolate 1 Isolate 6 Isolate 9 Isolate 12 Totals
Patients positive for virus 4 4/4 3/4 4/4 3/3 14/15
Patients negative for virus 8 1/8 1/8 0/8 1/8 3/32
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ritis, where virus can be isolated from the synovial fluid in patients with a high
serum antibody titer [10].
Naturally, we have been concerned with the possibility of contaminating agents.
For controls, uninoculated cultures were maintained in every test; many were used
for passage along with the inoculated cultures, but characteristic, passageable cell
changes were not produced in such control cultures. Tests for mycoplasma were
negative when third passage virus harvests of the four strains described in this paper
and a fifth strain isolated from the CSF of another MS patient were inoculated into
diphasic broth and onto E-agar plates [11]. In addition, the cytopathic changes were
not inhibited by antimycoplasma drugs such as tylocine at 60Ag/ml or gentamicin at
25 Ag/ml.
Further, the selective neutralization of the virus by sera from the patients who
yielded the agent indicates that we are not dealing with a contaminant. The possi-
bility of contamination of our cultures by the agent previously isolated in Japan is
ruled out by repeated isolations of the virus from the positive spinal fluids during
periods when the Japanese agent was not being cultivated in our laboratory. Also,
the selective neutralization tests mentioned above militate against such contamina-
tion.
There have been many attempts to isolate viruses from patients with MS, and in-
deed about ten viruses have been incriminated at one time or another over the past
35 years. However, in every case further research has disproved the original claim.
The viruses observed have been those common to humans, the most recent "can-
didates" being coronaviruses, measles virus, canine distemper virus, and herpes
simplex virus. Further work is now being done with these agents, particularly with
the new method of nucleic acid hybridization.
In our preliminary work we have isolated four antigenically related agents from
the CSF of three patients with MS and one patient with ALS. The patients yielding
the isolates from their CSF possessed neutralizing antibodies to the virus in their
blood, in contrast to several other patients with chronic CNS diseases who failed to
yield the virus and also failed to manifest neutralizing antibodies. The agent has not
yet been adequately characterized but it deserves further attention because it seems
to be a hitherto unknown virus, difficult to isolate and difficult to work with in the
laboratory. Its presence in the four patients mentioned above (and in several other
MS patients) warrants further investigation ofits potential role in MS and other pro-
gressive diseases of the the CNS. It is conceivable that infection with the agent may
provoke different immunopathological responses, leading to MS in some patients
and to ALS in others. However, this is conjecture.
We are having difficulty in characterizing our agent. In spite of much effort, we
have been unable to visualize the agent in the electron microscope, either in infected
cells or in purified concentrates. From our preliminary data, we suspect that we may
be dealing with an agent similar to scrapie. A puzzling aspect of these agents is their
"invisibility" by electron microscopy, despite the fact that estimates of their size,
based on their retention by filters having pores of known dimensions, show them to
be large enough for detection by electron microscopy. Our agent passes a 100-nm
filter, but seems to be held back by a 50-nm filter. It is not sedimented in the ultra-
centrifuge when spun at 35,000 x g for 1 hour, but is sedimented at 175,000 x g for
2 hours. Like the scrapie agent, its infectivity is destroyed by ether, but it is inac-
tivated by heating at 50°C. It has been suggested that scrapie-like agents do not
possess any nucleic acid with which to reproduce themselves [12]. Such infectious
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proteins, called prions, may act as infectious agents by invading susceptible cells,
where they are replicated by utilizing the DNA of the host cell [13]. Reorganizing
host DNA fragments may result in the formation of new genes which then direct the
synthesis of the original infectious proteins. Rather than a conventional virion, we
may have isolated such an infectious protein. Time will tell.
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